Table 1 Descriptive statistics of the three studied groups regarding the different studied parameters
From: Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients
Parameter | HCC, n = 30 | Liver cirrhosis, n = 15 | Healthy control, n = 15 | |
|---|---|---|---|---|
AST (IU/L) | Median (IQR) | 62 (45–90) | 44 (40–66) | 22 (19–22) |
ALT (IU/L) | Median (IQR) | 40 (26–76) | 39 (23–65) | 23 (15–27) |
Total bilirubin (mg/dL) | Median (IQR) | 1.9(1.0–3.2) | 1.4(0.9–2.3) | 0.9(0.7–1.0) |
Direct bilirubin (mg/dL) | Median (IQR) | 1.0 (0.6–2.0) | 0.9 (0.5–1.5) | 0.1 (0.0–0.2) |
Albumin (g/dL) | Mean ± SD | 2.6 ± 0.2 | 2.7 ± 0.3 | 4.5 ± 0.2 |
INR | Median (IQR) | 1.5 (1.2–1.7) | 1.3 (1.1–1.6) | 0.9 (0.8–1.0) |
AFP (ng/mL) | Median (IQR) | 220(35–706) | 2.9 (1.2–4.1) | 1.3 (1–3.3) |